TaiLong Capital
Venture Capital
Tailong Capital is a China-based private equity firm focused on biopharmaceuticals, medical devices, and healthcare investments.
3+ investments · 2 portfolio companies
Early Stage
Growth
Biotech
Healthcare
- Founded
- 2021
- Website
- tailongcapital.com
- AUM
- $20.0B
- Portfolio Companies
- 2
- Total Investments
- 3
- Last Investment
- Nov 2024
- Geographic Focus
- China
Investment Thesis
Tailong Capital invests in biopharmaceutical, medical device, and broader healthcare companies in China, backing clinical-stage and growth biotech firms via funds such as its Taikun Fund.
TaiLong Capital is a Venture Capital firm. It has made 3 investments, including Lynk Pharmaceuticals and C-Ray Therapeutics. Focus areas include Biotech and Healthcare.
Portfolio2
Co-investors10
Sign up to view co-investors
10 co-investors across 10 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×9 · Other ×1 · 6 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/tailong-capital"><img src="https://indexed.vc/api/badge/investor/tailong-capital" alt="TaiLong Capital on Indexed.vc" width="260" height="76" /></a>